GAMCO Investors, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:GAMCO Investors, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5616
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GAMCO Investors, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

GAMCO Investors, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GAMCO Investors, Inc. (GAMCO) is a provider of investment advisory services to open-and close-ended funds, and private wealth and institutional management investors. It manages assets on a discretionary basis and invests in securities by various investment styles. The company offers advisory related to corporate retirement plans, endowments, foundations, jointly-trustees plans, private wealth clients, and serves as sub-advisor to third-party investment funds. It operates through branch offices, international representative offices, and online portals to high-net-worth individuals and institutions in the US, the UK, and Japan. GAMCO is headquartered in Rye, New York, the US.

Scope

- Detailed information on GAMCO Investors, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GAMCO Investors, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of GAMCO Investors, Inc. including a breakdown and examination of key business segments
- Intelligence on GAMCO Investors, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GAMCO Investors, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GAMCO Investors, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GAMCO Investors, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GAMCO Investors, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
GAMCO Investors, Inc.: Company Overview 9
GAMCO Investors, Inc.: Overview and Key Facts 9
GAMCO Investors, Inc.: Overview 9
GAMCO Investors, Inc.: Key Facts 9
GAMCO Investors, Inc.: Key Employees 11
GAMCO Investors, Inc.: Key Employee Biographies 12
GAMCO Investors, Inc.: Major Products and Services 13
GAMCO Investors, Inc.: Company History 14
GAMCO Investors, Inc.: Management Statement 17
GAMCO Investors, Inc.: Locations and Subsidiaries 20
GAMCO Investors, Inc.: Key Competitors 22
GAMCO Investors, Inc.: Company Analysis 23
GAMCO Investors, Inc.: Business Description 23
GAMCO Investors, Inc.: SWOT Analysis 24
GAMCO Investors, Inc.: SWOT Overview 24
GAMCO Investors, Inc.: Strengths 24
GAMCO Investors, Inc.: Weaknesses 24
GAMCO Investors, Inc.: Opportunities 25
GAMCO Investors, Inc.: Threats 25
GAMCO Investors, Inc.: Corporate Financial Deals Activity 27
GAMCO Investors, Inc.: Financial Deals Overview 27
GAMCO Investors, Inc.: Targets and Partners 28
GAMCO Investors, Inc.: Top Deals 2014 – 2018YTD* 29
GAMCO Investors, Inc.: Advisors 30
GAMCO Investors, Inc.: Top Legal Advisors 30
GAMCO Investors, Inc.: Top Financial Advisors 30
GAMCO Investors, Inc.: Mergers and Acquisitions 31
GAMCO Investors, Inc.: Corporate Venturing 32
GAMCO Investors, Inc.: Capital Raising 33
GAMCO Investors, Inc.: Divestments 34
GAMCO Investors, Inc.: Private Equity and Ownership 35
GAMCO Investors, Inc.: Recent Developments 36
GAMCO Investors, Inc.: News and Events Summary 36
GAMCO Investors, Inc.: Business Expansion 37
GAMCO Investors, Inc.: Contracts 37
GAMCO Investors, Inc.: Corporate Governance 38
GAMCO Investors, Inc.: Financial Performance 38
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: GAMCO Investors, Inc.: Key Facts
Table 2: GAMCO Investors, Inc.: Key Employees
Table 3: GAMCO Investors, Inc.: Company History
Table 4: GAMCO Investors, Inc.: Locations and Subsidiaries
Table 5: GAMCO Investors, Inc.: Key Competitors
Table 6: GAMCO Investors, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: GAMCO Investors, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: GAMCO Investors, Inc.: Targets and Partners
Table 9: GAMCO Investors, Inc.: Top Deals 2014 - 2018YTD*
Table 10: GAMCO Investors, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: GAMCO Investors, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: GAMCO Investors, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: GAMCO Investors, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: GAMCO Investors, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: GAMCO Investors, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: GAMCO Investors, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: GAMCO Investors, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: GAMCO Investors, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: GAMCO Investors, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 20: GAMCO Investors, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 21: GAMCO Investors, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 22: GAMCO Investors, Inc.: News and Events Summary
Table 23: GAMCO Investors, Inc.: Business Expansion
Table 24: GAMCO Investors, Inc.: Contracts
Table 25: GAMCO Investors, Inc.: Corporate Governance
Table 26: GAMCO Investors, Inc.: Financial Performance

List of Figures
Figure 1: GAMCO Investors, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: GAMCO Investors, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: GAMCO Investors, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: GAMCO Investors, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: GAMCO Investors, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: GAMCO Investors, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: GAMCO Investors, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: GAMCO Investors, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: GAMCO Investors, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: GAMCO Investors, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 11: GAMCO Investors, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: GAMCO Investors, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[GAMCO Investors, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MicuRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …
  • Fenwal Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • Golden Meditech Holdings Ltd (801):医療機器:M&Aディール及び事業提携情報
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Husky Energy Inc (HSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Husky Energy Inc (Husky) is an integrated energy company. It operates across the oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen, natural gas and natural gas liquids (NGL). Its midstream operations include pipeline tr …
  • Stemcor Global Holdings Ltd:企業の戦略・SWOT・財務情報
    Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Caplin Point Laboratories Ltd (CAPLIPOINT):企業の財務・戦略的SWOT分析
    Summary Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures creams, ointments, and other external application products. The company’s products in regulated market include opthalmic products, liquid injections and lyophilised injections. It also offers softgel c …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • VeriFone Systems Inc:企業の戦略・SWOT・財務分析
    VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report Summary VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clinova Ltd:企業の戦略的SWOT分析
    Clinova Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Co-operative Group Ltd:企業の戦略・SWOT・財務分析
    Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Commercial Bank Of Kuwait Sak:企業の戦略・SWOT・財務分析
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AdvantEdge Healthcare Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Digimarc Corp (DMRC):企業の財務・戦略的SWOT分析
    Summary Digimarc Corp (Digimarc) is a technology company that offers develops solutions, license intellectual property and provides development services to businesses and government. The company offers products such as digimarc discover, online image safeguards and digimarc guardian. Digimarc’s Disc …
  • Vascular Concepts Ltd:企業の製品パイプライン分析2018
    Summary Vascular Concepts Ltd (Vascular Concepts) formerly known as Medical Concepts Ltd is a medical device company that designs, develops and manufactures endovascular medical devices for the treatment of arterial diseases. Its products include coronary stents, peripheral stents and balloon. Vascu …
  • Aphios Corp-製薬・医療分野:企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • Resilux NV:企業の戦略・SWOT・財務情報
    Resilux NV - Strategy, SWOT and Corporate Finance Report Summary Resilux NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Calpine Corporation (CPN)-エネルギー分野:企業M&A・提携分析
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • Collegium Pharmaceutical Inc (COLL):製薬・医療:M&Aディール及び事業提携情報
    Summary Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆